MMF Influence on HCV Viral Evolution After Liver Transplantation

Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients

NCT00703560 ·Status: COMPLETED

The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System

NCT01206933 ·Status: COMPLETED

Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.

NCT00671671 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1)

NCT02265237 ·Status: COMPLETED ·Phase: PHASE3

Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 Patients

NCT00680173 ·Status: COMPLETED ·Phase: PHASE4

Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced

NCT00793793 ·Status: COMPLETED ·Phase: PHASE1

Viral Kinetics in HCV Clearance in Subjects With Hemophilia

NCT01704521 ·Status: COMPLETED ·Phase: PHASE1

Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting

NCT00222859 ·Status: COMPLETED

Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C

NCT00322179 ·Status: COMPLETED

Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers

NCT00211848 ·Status: COMPLETED ·Phase: PHASE2

Multiple Oral Doses of BI 207127 NA in Treatment naïve and Treatment-experienced Hepatitis C Virus (HCV)-Infected Patients

NCT02176525 ·Status: COMPLETED ·Phase: PHASE1

Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System

NCT06508996 ·Status: COMPLETED

Durability of Virologic Response and/or Viral Resistance Patterns in Participants With Chronic Hepatitis C Who Have Been Previously Treated With Grazoprevir (MK-5172) (MK-5172-017)

NCT01667081 ·Status: COMPLETED

A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection

NCT02356562 ·Status: COMPLETED ·Phase: PHASE2

Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis

NCT02455167 ·Status: TERMINATED ·Phase: PHASE3

Immune Response to Hepatitis C Virus

NCT00165919 ·Status: WITHDRAWN

Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1

NCT02629172 ·Status: COMPLETED

A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1

NCT00790673 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Hepatitis C Virus and the Humoral Immune System

NCT00219999 ·Status: COMPLETED

Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection

NCT01560468 ·Status: TERMINATED ·Phase: PHASE1

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

NCT00100581 ·Status: COMPLETED ·Phase: NA

Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected Patients

NCT01964742 ·Status: COMPLETED ·Phase: NA

Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation

NCT01463956 ·Status: COMPLETED ·Phase: PHASE2

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease

NCT00516321 ·Status: COMPLETED ·Phase: PHASE3

Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)

NCT03002818 ·Status: COMPLETED